Yale School of Medicine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Yale School of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011924
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yale School of Medicine (YSM), a subsidiary of Yale University is an educational service provider that offers bio-medical research, education and advanced health care. The center provides degree programs such as public health program, physician associate program, other PhD programs, medical degree program, nursing program, and others. It provides joint degrees with other Yale professional schools. The center offers research studies in the areas of epidemiology and public health, cell biology, biomedical engineering, comparative medicine, genetics, cellular and molecular physiology, and among others. It also provides patient care and clinical trial services. YSM is headquartered in New Haven, Connecticut, the US.

Yale School of Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Yale School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Yale School of Medicine, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 11
Organovo Enters into Co-Development Agreement with Yale School of Medicine 12
Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine 13
Licensing Agreements 14
NextCure Enters into Licensing Agreement with Yale School of Medicine 14
Yale School of Medicine – Key Competitors 15
Yale School of Medicine – Key Employees 16
Yale School of Medicine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Oct 11, 2017: Forray study reveals potential new treatment for postpartum smokers 19
Jul 13, 2017: Heart Study Finds Faulty Link Between Biomarkers And Clinical Outcomes 20
Feb 14, 2017: Study points to potential new brain cancer treatment 21
Apr 15, 2016: Yale researchers discover drug target in rare, lethal glandular cancer 22
Product News 23
Sep 20, 2016: Two mood drugs combat virus implicated in birth defects 23
Other Significant Developments 24
Oct 17, 2017: Yale launches new program in addiction medicine 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Yale School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Yale School of Medicine, Deals By Therapy Area, 2011 to YTD 2017 8
Yale School of Medicine, Medical Devices Deals, 2011 to YTD 2017 9
Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 11
Organovo Enters into Co-Development Agreement with Yale School of Medicine 12
Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine 13
NextCure Enters into Licensing Agreement with Yale School of Medicine 14
Yale School of Medicine, Key Competitors 15
Yale School of Medicine, Key Employees 16
Yale School of Medicine, Subsidiaries 18

★海外企業調査レポート[Yale School of Medicine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Landmarks Berhad:企業の戦略・SWOT・財務情報
    Landmarks Berhad - Strategy, SWOT and Corporate Finance Report Summary Landmarks Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Canadian Energy Services & Technology Corp (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • Georgia Power Co:発電所・企業SWOT分析
    Georgia Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • XCD Energy Ltd (XCD):企業の財務・戦略的SWOT分析
    XCD Energy Ltd (XCD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Australian Vintage Limited:企業の戦略・SWOT・財務分析
    Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • WellCare Health Plans, Inc.:企業の戦略・SWOT・財務情報
    WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report Summary WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fronius International GmbH:企業の戦略的SWOT分析
    Fronius International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mauna Kea Technologies SAS (MKEA)-医療機器分野:企業M&A・提携分析
    Summary Mauna Kea Technologies SAS (MKT) is a medical device company that develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. The company’s product includes cellvizio. Its cellvizio is an endomicroscopy platform that provides micr …
  • Milestone Scientific Inc (MLSS):企業の財務・戦略的SWOT分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields. The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, …
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Arsenal Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Arsenal Medical Inc (Arsenal) is a medical technology company that develops polymer based foams and fibers. The company’s products comprise foam system for acute hemorrhage and DARPA collaboration products. Its foam system is an in-situ foaming foams, which is designed for the control of sev …
  • GrafTech International Ltd:企業の戦略・SWOT・財務情報
    GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report Summary GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bouygues SA (EN):電力:M&Aディール及び事業提携情報
    Summary Bouygues SA (Bouygues) is an industrial group which operates in construction, real estate development, media and telecommunication markets. It undertakes construction contracts for roads, airport runways, seaport, industrial infrastructure, parking areas, recreational facilities, electrical …
  • PartnerRe Ltd.:企業の戦略・SWOT・財務情報
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • Capita plc:企業の戦略・SWOT・財務分析
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Karur Vysya Bank Ltd:企業の戦略・SWOT・財務情報
    Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lincoln Electric System:企業の戦略的SWOT分析
    Lincoln Electric System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sterling Bank Plc:企業の戦略・SWOT・財務分析
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Pakistan Water and Power Development Authority-エネルギー分野:企業M&A・提携分析
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆